Market cap
$1.1b
End-of-day close multiplied by current shares on issue.
Result releasedAnnolyse analysis published
Underlying earnings progress is modest and clean, but a NZ$449m step-up in borrowings and deeply negative operating cash define the period.
Comparable chart history for this briefing.
Market context
A close-dated read on what the market price implies next to the latest verified filing inputs. Unavailable metrics stay visible when the absence is useful context.
The latest close and share count context for the market price.
Market cap
$1.1b
End-of-day close multiplied by current shares on issue.
How the market price compares with recent earnings and cash-flow inputs.
P/E
13.5x
Recent market cap compared with trailing earnings.
EPS
0.09
Recent filing-derived earnings per share.
PEG
0.01x
P/E compared with recent earnings growth.
EV/EBITDA
Not available
Not useful for this reporting shape.
P/FCF
Not available
Not available for this company right now.
P/B
0.88x
Market value compared with latest reported equity.
Yield and fund-style valuation where the company shape supports it.
Dividend yield
4.6%
Trailing dividends compared with the latest close.
Total return
Not available
Available once dividend and adjustment data are verified.
Key metrics
HY22 vs HY21
Revenue
$130.8m
Caveat: metric quality flags apply; use this value with basis context.
Net profit after tax
$47.5m
Caveat: metric quality flags apply; use this value with basis context.
Net cash inflow from operating activities
−$142.3m
Caveat: metric quality flags apply; use this value with basis context.
Interim dividend per share
5.5c
+37.5% ↑ vs 4.0c
Operating profit
$73.5m
Caveat: metric quality flags apply; use this value with basis context.
Cash and cash equivalents
$207.7m
+35.9% ↑ vs $152.8m
Total assets
$6b
Caveat: metric quality flags apply; use this value with basis context.
Analysis ofHGH HY22Result releasedAnnolyse analysis published
What changed
The headline progress is overshadowed by balance-sheet activity: gross borrowings rose 32.6% to NZ$1.8b and total assets grew 10.3% to NZ$6b, funding rapid loan-book expansion.
Operating cash outflow widened sharply from NZ$5.3m to NZ$142.3m, and pre-lease free cash flow of NZ$-150.9m is classified as an unprecedented low in Annolyse's historical baseline (4-period mean NZ$190.2m, range NZ$-25.5m to NZ$297.2m). Despite that, the interim dividend was lifted 37.5% to 5.5 cents per share.
Segment growth was concentrated in Australia (revenue +15.6%, derived margin 62.4% → 73.8%) and Reverse Mortgages (revenue +36.6%, share of group up 2.4pp), while Rural was flat and its result slipped from NZ$14.0m to NZ$13.1m.
What matters
Borrowings jumped NZ$448.5m in six months to fund finance-receivable growth, and the resulting NZ$142.3m operating cash outflow swamps the NZ$47.5m of profit. For a lender this pattern is normal when a book is growing, but it means current-period earnings are not the same thing as cash generated, and the equity base (NZ$778.2m, +5.6%) is supporting a materially larger asset stack.
Growth mix is shifting toward longer-duration and offshore assets. Reverse Mortgages and Australia together added share, with Australia's derived segment margin expanding more than 11 percentage points. That is the visible driver of group margin strength, but it also concentrates new exposure in two books whose credit and funding profiles differ from the legacy New Zealand business.
Dividend was raised against negative cash. Interim DPS rose 37.5% and payout to NPAT stepped up to 68.1% from 50.0% prior. Pre-lease FCF coverage is -21.4%, so the increase is being funded from wholesale and deposit growth rather than period cash – defensible while the loan book is profitable and growing, but a question if growth slows.
Expectations
The only shape reference available is HY21, which represented 47.8% of FY21 revenue and 50.7% of FY21 NPAT, indicating a marginally second-half-weighted prior year. Annualising HY22 gives implied revenue near NZ$261.6m, which would extend the recent low-single-digit revenue-growth pattern in the historical baseline (4-period mean 7.3%).
What the release does not support is any read on credit-cost trajectory, funding mix, or net interest margin stability into 2H. Those gaps matter because the period's reported earnings growth sits on a balance sheet that has expanded much faster than equity.
Quality of result
PBT growth (+8.9%) is only 1.2 percentage points ahead of NPAT growth (+7.7%), the effective tax rate of 26.8% is close to the 26.1% prior, and ROE edged up to 6.1% from 6.0% – all within the supplied historical range. PBT margin of 49.6% is above Annolyse's historical baseline (4-period mean 32.0%, range 3.4%–47.9%), reflecting the Australia and Reverse Mortgage mix shift; durability depends on whether those segment margins hold as the books season.
The cash picture is the weak point, but it should be read as balance-sheet driven rather than earnings-quality driven. Capex was only NZ$8.6m (6.6% of revenue); the NZ$150.9m pre-lease FCF outflow is essentially the lending growth funded by the 32.6% rise in borrowings. The implication is that none of the reported NPAT was self-funded this period, and dividend cover relies on continued access to wholesale and depositor funding rather than on operating cash.
Unresolved
This briefing cannot assess net interest margin, credit-impairment trends, funding-mix composition, or capital adequacy because those disclosures are not in the supplied extraction.
Chat
Ask follow-up questions about Heartland Group Holdings's HY22 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
Heartland - 1H2022 Investor presentation
HY22 / results presentationHeartland - 1H2022 Results Release
HY22 / results releaseHeartland - HGH Financial statements
HY22 / financial reportHeartland - NZX Results Announcement (template form)
HY22 / results announcementHeartland - 1H2021 Results Release
HY21 / results releaseHeartland - HGH Financial statements
HY21 / financial reportHeartland - NZX Results Announcement (template form)
HY21 / results announcementHeartland Group Holdings Financial Statements
FY21 / financial reportHeartland NZX Results Announcement Template
FY21 / results announcementHeartland NZX Results Announcement Template
FY21 / results releaseHeartland Annual Meeting to be held online only
HY22 / commentaryRelated insights
Cross-company views selected from the metrics in this briefing.
Dividend coverage and payout pressure
Dividend payout versus NPAT is 68.1%.
Earnings quality and statutory distortions
PBT and NPAT growth diverged by 1.2pp.
Revenue growth context
Revenue growth was 8.9% for this reporting period.
ROE and capital efficiency
ROE was 6.1%, +0.1pp versus the prior comparable period.
Get the next Heartland Group Holdings briefing and related NZX reporting-season updates by email.